Relay Therapeutics Inc. (RLAY)
Market Closed
2 Mar, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
9. 79
-0.47
-4.58%
$
1.78B Market Cap
- P/E Ratio
- Div Yield
2,840,424 Volume
-2.94 Eps
$ 10.26
Previous Close Day Range
9.77 10.68
Year Range
1.77 11.43
Want to track RLAY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
RLAY earnings report is expected in 62 days (4 May 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
RLAY Earnings Reports FAQ
What is the earnings per share (EPS) for RLAY?
The current EPS is -2.94.
What is the company's earnings growth rate?
Relay Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-05-04, based on the RLAY's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Relay Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for RLAY at this time, as Relay Therapeutics Inc has no recent EPS data to calculate it.
